Published in Eur Heart J on March 28, 2017
Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol (2015) 2.61
Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg (2008) 2.31
Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J (2005) 1.75
REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis (2008) 1.42
The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort study. PLoS One (2015) 1.40
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg (2008) 1.01
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med (2015) 0.97
A prediction model for left ventricular mass in patients at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil (2010) 0.97
The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk. Eur Heart J (2013) 0.94
Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease. Atherosclerosis (2008) 0.94
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study. Expert Opin Drug Deliv (2015) 0.90
Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease. J Intern Med (2008) 0.89
Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol (2016) 0.89
Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients. J Hum Hypertens (2008) 0.87
Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus. Eur J Clin Invest (2013) 0.84
The interdependence between cardiovascular calcifications in different arterial beds and vascular risk factors in patients at high cardiovascular risk. Atherosclerosis (2014) 0.83
The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease. Eur J Clin Invest (2010) 0.82
The prevalence of obesity-related hypertension and risk for new vascular events in patients with vascular diseases. Obesity (Silver Spring) (2012) 0.81
High total cerebral blood flow is associated with a decrease of white matter lesions. J Neurol (2004) 0.81
Cerebellar infarct patterns: The SMART-Medea study. Neuroimage Clin (2015) 0.79
Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases. Eur J Prev Cardiol (2011) 0.78
Parental history and the risk of subsequent vascular events in patients with clinically manifest vascular disease: the effects of sex of the parent and vascular disease location. Atherosclerosis (2014) 0.78
Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease. Int J Obes (Lond) (2014) 0.78
Extracellular vesicle-derived CD14 is independently associated with the extent of cardiovascular disease burden in patients with manifest vascular disease. Eur J Prev Cardiol (2014) 0.78
The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-year follow-up data from the Australian REACH registry. Cardiovasc Ther (2013) 0.78
Plasma triglyceride levels increase the risk for recurrent vascular events independent of LDL-cholesterol or nonHDL-cholesterol. Int J Cardiol (2012) 0.78
Brain volumes and risk of cardiovascular events and mortality. The SMART-MR study. Neurobiol Aging (2014) 0.77
Predictors of health care use among patients with or at high risk of atherothrombotic disease: two-year follow-up data. Int J Cardiol (2014) 0.77
Trends in vascular risk factors and medication use in patients with various manifestations of vascular diseases or type 2 diabetes mellitus from 1996 to 2007: the Second Manifestations of ARTerial disease study. Eur J Cardiovasc Prev Rehabil (2010) 0.77
Effect of Type 2 Diabetes on Recurrent Major Cardiovascular Events for Patients With Symptomatic Vascular Disease at Different Locations. Diabetes Care (2015) 0.76
Prevalence and risk of cardiovascular risk factors and events in offspring of patients at high vascular risk and effect of location of parental vascular disease. Int J Cardiol (2015) 0.76
The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk. Am Heart J (2015) 0.76
A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction. PLoS One (2015) 0.76
Association between CETP gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular disease. Atherosclerosis (2015) 0.76
Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study. BMC Cardiovasc Disord (2011) 0.75
Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Cardiovasc Electrophysiol (2016) 0.75
Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort study. Diabetes Care (2015) 0.75
Inter-arm systolic blood pressure differences, relations with future vascular events and mortality in patients with and without manifest vascular disease. Int J Cardiol (2017) 0.75
HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care (2016) 0.75
Response to Comment on Sharif et al. HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes Care 2016;39:1424-1430. Diabetes Care (2016) 0.75
Apparent resistant hypertension and the risk of vascular events and mortality in patients with manifest vascular disease. J Hypertens (2017) 0.75
The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease. J Am Coll Cardiol (2016) 0.75
Risk Factors for Recurrent Cardiovascular Events Before Age 65 Years or Within 2.5 Years of a Recent First Cardiovascular Event. Am J Cardiol (2017) 0.75
Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis. Int J Cardiol (2017) 0.75
Leisure-time physical activity and risk of type 2 diabetes in patients with established vascular disease or poorly controlled vascular risk factors. Diabetes Res Clin Pract (2010) 0.75
Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease. Eur J Prev Cardiol (2015) 0.75
Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes. Int J Cardiol (2016) 0.75
Relation between cardiovascular disease risk factors and epicardial adipose tissue density on cardiac computed tomography in patients at high risk of cardiovascular events. Eur J Prev Cardiol (2016) 0.75
Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosis. Int J Cardiol (2017) 0.75
High ratios of kidney function to kidney size are related to mortality and kidney function decline in high-risk patients. Eur J Prev Cardiol (2017) 0.75
Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes. Int J Cardiol (2017) 0.75
High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease. J Am Heart Assoc (2017) 0.75